Loading...

Theranostics in immuno-oncology using nanobody derivatives

Targeted therapy and immunotherapy have become mainstream in cancer treatment. However, only patient subsets benefit from these expensive therapies, and often responses are short‐lived or coincide with side effects. A growing modality in precision oncology is the development of theranostics, as this...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Theranostics
Main Authors: Lecocq, Quentin, De Vlaeminck, Yannick, Hanssens, Heleen, D'Huyvetter, Matthias, Raes, Geert, Goyvaerts, Cleo, Keyaerts, Marleen, Devoogdt, Nick, Breckpot, Karine
Format: Artigo
Sprog:Inglês
Udgivet: Ivyspring International Publisher 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6831473/
https://ncbi.nlm.nih.gov/pubmed/31695800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.34941
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!